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Abstract
Background: The aim of this study was to quantify the variability in spinal radiosurgery (SRS) planning practices
between five international institutions, all member of the Elekta Spine Radiosurgery Research Consortium.
Methods: Four institutions provided one representative patient case each consisting of the medical history, CT and
MR imaging. A step-wise planning approach was used where, after each planning step a consensus was generated
that formed the basis for the next planning step. This allowed independent analysis of all planning steps of CT-MR
image registration, GTV definition, CTV definition, PTV definition and SRS treatment planning. In addition, each
institution generated one additional SRS plan for each case based on intra-institutional image registration and
contouring, independent of consensus results.
Results: Averaged over the four cases, image registration variability ranged between translational 1.1 mm and 2.4 mm
and rotational 1.1° and 2.0° in all three directions. GTV delineation variability was 1.5 mm in axial and 1.6 mm in
longitudinal direction averaged for the four cases. CTV delineation variability was 0.8 mm in axial and 1.2 mm in
longitudinal direction. CTV-to-PTV margins ranged between 0 mm and 2 mm according to institutional protocol.
Delineation variability was 1 mm in axial directions for the spinal cord. Average PTV coverage for a single fraction18 Gy
prescription was 87 ± 5 %; Dmin to the PTV was 7.5 ± 1.8 Gy averaged over all cases and institutions. Average Dmax to the
PRV_SC (spinal cord + 1 mm) was 10.5 ± 1.6 Gy and the average Paddick conformity index was 0.69 ± 0.06.
Conclusions: Results of this study reflect the variability in current practice of spine radiosurgery in large and highly
experienced academic centers. Despite close methodical agreement in the daily workflow, clinically significant variability
in all steps of the treatment planning process was demonstrated. This may translate into differences in patient clinical
outcome and highlights the need for consensus and established delineation and planning criteria.
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Introduction
Cancer patients with systemic tumor spread frequently
develop skeletal metastases. Many of these occur within
the spine [1–3]. Radiotherapy (RT) is an established and
recommended component of the multidisciplinary treat-
ment of spine metastases with regard to prevention of
pathologic fractures or neurological deficits and pain
palliation [4–6]. Conventional RT with low dose per
fraction is effective but has been shown to achieve only
a rather short duration of pain response of only 3–6
months (median) [7]. Improvements in systemic treat-
ment efficacy have prolonged survival in many cancer
patients. Also, validated overall survival scores have been
described for patients treated with spine metastases that
has enabled identification of patient subgroups with
longer survival [8–10].
Spine Stereotactic Radiosurgery (SRS), sometimes also
referred to as Stereotactic Body Radiation Therapy
(SBRT) to the spine, has been demonstrated to result in
promising long term local control and pain palliation
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with low toxicity rates [11–16]. The use of SRS as an al-
ternative treatment to conventional RT has been in-
creasing rapidly. However, there still remains significant
variability and little consensus exist regarding target vol-
ume contouring and treatment planning [17–19].
The aim of this study was to quantify the variability in
SRS planning practice between five experienced inter-
national centers. This planning study is based on 4 pa-
tient cases with representative tumor lesions in 1–2
vertebrae.
Materials and methods
Patient cases
All centers were experienced in spine RS planning and de-
livery and were members of the Elekta Spine Radiosurgery
Research Consortium which included University Hospital
Wuerzburg, University of Pittsburgh School of Medicine,
William Beaumont Hospital, Princess Margaret Hospital,
University of Virginia School of Medicine. Four cases from
4 institutions were selected that covered the range of spine
RS practice. The epidural extension was Bilsky score 0, 1b
and 2 and paraspinal involvement was observed in 3 of 4
cases [20]. Detailed information on patient and tumor
characteristics is given in Table 1. Representative images
from each case are illustrated in Fig. 1.
Planning procedure
A step-wise planning procedure was performed such
that variability in all stages of the planning process were
analyzed independently: 1) CT-MR image registration 2)
gross-tumor volume (GTV) and organ at risk (OAR)
spinal cord delineation 3) clinical target volume (CTV)
and planning risk volume (PRV) definition 4) planning
target volume (PTV) definition 5) treatment planning
based on consensus contours and 6) treatment planning
based on institutional-specific contours. This was achieved
by providing consensus results after each step of the plan-
ning process, forming the basis for the next step.
The planning software for treatment planning was
Pinnacle3 in all institutions (Philips Radiation Oncology
Systems, Fitchburg, WI, USA) and some institutions
used additional software for image registration or delin-
eation depending on in house protocol.
Step 1: CT-MR image registration
The CT and MR images for each patient were electron-
ically provided to each institution. The CT images were
defined as reference image data set and the MR image as
secondary image set for image fusion. The registration
parameters were recorded in x (Left-Right), y (Anterior-
Posterior) and z (Superior-Inferior) directions. Only rigid
translations and rotations of the image sets were consid-
ered for each case.
Average registration results were calculated by taking
the mean value of all registration results and were con-
sidered to be the consensus results. These consensus
registration parameters were sent back to all institutions.
The consensus registration parameters were then used
for the following step of target definition.
Step 2: delineation of GTV and spinal cord
GTV and spinal cord (in one case with lumbar location -
thecal sac) delineation was performed according to the
institution specific in-house protocols in consideration
of the clinical case descriptions by all institutions. A
consensus for all case specific GTV and spinal cord con-
tours was calculated and distributed to the different in-
stitutions by the coordinating institution.
Step 3: delineation of CTV
Delineation of CTV was based on the consensus GTV.
According to step 2, a consensus for all case specific
contours was calculated and distributed to the different
institutions by the coordinating institution.
Step 4: definition of PTV and PRV
PTV definition was based on the consensus CTV. The
definition of the planning risk volume spinal cord
(PRV_SC) was based on the consensus spinal cord (in
one case with lumbar location, consensus spinal canal).
Once again, a consensus for all case specific contours
was calculated and distributed to the different institu-
tions by the coordinating institution.
Step 5: treatment planning based on consensus contours
The consensus PTV and the consensus PRV_SC were used
for treatment planning. Institution specific contouring of
relevant organs at risk (e.g. lungs…) and optimization
guiding structures for the dose optimization process was
allowed. Target volume prescription and normal tissue
constraints are given below (see Step 6).
Institution specific in-house planning objectives/con-
straints were used for generation of the treatment plan.
Both step-and-shoot IMRT as well as VMAT were allowed.
Table 1 Detailed patient status parameters
Patient case: 1 2 3 4
Sex F F F M
Age 55 61 63 55
Histology: Breast Breast Lung Renal
Pain Score VAS 7 5 6 -
Paraspinal involvement: Yes No Yes Yes
Bilsky score: 1b 0 0 2
Circumferential epidural disease: 180° 90° 90° 180°
Location: T 12-L1 C 2 T 7–8 L 3
Number of involved vertebras: 2 1 2 1
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All institutions used an Elekta Synergy S/Axesse equipped
with the Beam Modulator MLC (4 mm leaf width) for
treatment planning (Elekta Beam Modulator™, Elekta On-
cology Systems, Crawley, UK). Photon energies of 6 MV
and 10 MV were used for treatment planning according to
individual in-house protocols and depending on tumor lo-
cation. Doses were calculated with a 2 mm grid size and
collapsed cone convolution algorithm.
Step 6: treatment planning based on institutional-specific
CTV contours
Treatment planning was repeated with institutional-
specific GTV and CTV contours and institution specific
PTV and OAR delineation by all institutions for all cases
by using the identical planning objectives/constraints as
in the previous planning step 5.
Objectives and constraints for this planning study
The prescription dose to the PTV was 18 Gy in a single
fraction. An attempt was made to achieve a PTV cover-
age of at least 90 % by the prescription dose. Coverage
of 80–90 % of the target volume was acceptable. A mini-
mum coverage of <80 % of the target volume was an un-
acceptable deviation. Dose inhomogeneity within the
target volume was allowed.
The dose to the normal tissue was limited by consider-
ing the tolerance dose values as listed in Table 2 which
was adapted from RTOG 0631 Study [21].
Calculation of consensus structures
For each structure GTV, CTV and SC a consensus struc-
ture was determined such that each voxel encompassed
by at least two institutions was included in the consen-
sus structure. Only one outlier was excluded (Fig. 2).
Method for calculation of delineation variability
The consensus structure formed the basis for calculation
of delineation variability. The shortest distance in each
direction (Euclidean distance) was calculated between
the consensus structure and the institutional structures
to obtain an estimation of delineation variability for
these irregular shaped contours (Fig. 2).
Method for dosimetric plan comparison
The dose distribution of the treatment plans was evalu-
ated by determining minimum dose (Dmin), mean dose
Case 1 Case 2 Case 3 Case 4
Fig. 1 Representative slices from T2 weighted MR images of all patient cases. Case 1,3,4 are presented in axial view and case 2 in sagittal view
Table 2 Normal tissue constraints
Serial tissue Volume in
cm3
Dose Max
in Gy
Endpoint
(> Grade 3)
Spinal cord <0.035 14 Myelitis
<0.35 10
<1.2 7
Cauda Equina <0.035 16 Neuritis
<5 14
Sacral Plexus <0.035 18 Neuropathy
<5 14.4
Esophagusa <0.035 16 stenosis/fistula
<5 11.9
Heart/Pericardium <0.035 22 Pericarditis
<15 16
Great vesselsa <0.035 37 Aneurysm
<10 31
Tracheaa and Larynx <0.035 20.2 stenosis/fistula
<4 10.5
Skin <0.035 26 Ulceration
<10 23
Stomach <0.035 16 ulceration/
fistula
<10 11.2
Renal hilum/vascular
trunk
<2/3 volume 10.6 malignant
hypertension
Parallel tissue Critical volume
in cm3
Dose Max Endpoint
(> Grade 3)
Lung (Right & Left) 1000 7.4 Pneumonitis
Renal cortex (Right
& Left)
200 8.4 Basic renal
function
a Avoid circumferential irradiation
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(Dmean), maximum dose (Dmax). The dose volume pa-
rameters according to ICRU Report 83 [22] D98, D95,
D90, D05, D02 and V18Gy were acquired for the PTV. The
D98 of the PTV is the dose which encompasses 98 % of
the PTV. Additionally, V18Gy describes the part of the
PTV which is treated with 18 Gy while V-Abs18Gy is the
total body volume treated with 18 Gy (including normal
tissue). For the PRV_SC the parameters Dmax, D0,1ccm,
V8Gy, V10Gy were acquired.
The dose distributions were compared using the fol-
lowing parameters: conformity, homogeneity and target
coverage, according to the RTOG recommendation [23].
Additionally, the Paddick conformity index was also de-
termined [24]. The RTOG conformity index (CI-RTOG)
represents the ratio of the volume encompassed by the
prescription isodose to the target volume. Three categor-
ies of conformity index protocol compliance were de-
fined. Plans with a conformity index value between 1.0
and 2.0 are in the normal range and are classified as not
deviating from RTOG protocol. Conformity index value
between 2.0 and 2.5 or between 0.9 and 1.0 are classified
as having minor deviations. Value greater than 2.5 or less
than 0.9 show major deviations of the dose from the
RTOG protocol.
The RTOG homogeneity index (HI-RTOG) represents
the ratio of maximum dose within the target volume to
the prescribed dose. The normal range is up to 2.0, it in-
dicates a minor deviation if HI-RTOG > 2.0 and a major
deviation if HI-RTOG > 2.5.
The RTOG coverage (Cov-RTOG) describes the ratio
between minimum dose within the target volume and
the prescribed dose, it indicates a minor deviation if <0.9
and a major deviation if <0.8.
The Paddick conformity index (CI-Paddick) describes
the ratio of the squared target volume covered by the
prescription isodose to the arithmetic product of target
volume and prescription isodose total volume. This
equals the multiplication of the undertreatment ratio
and the overtreatment ratio. This index has an ideal
value of one and plan quality decreases with decreasing
index value.
Results
Step 1: CT-MR image registration
The results of image registration are listed in Table 3.
For each case, the standard deviation and maximum
range between all institutional results were calculated.
Fig. 2 Schematic illustration of how the delineation variability was determined
Table 3 Registration variability between the five institutions
case X in mm Y in mm Z in mm rot X in ° rot Y in ° rot Z in °
Max range 1 4.7 2.2 2.7 3.1 0.8 4.4
2 1.7 1.1 6.5 1.2 3.7 3.8
3 1.8 15.9 11.8 4.1 2.9 4.5
4 2.6 2.5 3.0 12.5 2.6 3.5
average 1–4 2.7 5.4 6.0 5.2 2.5 4.1
average 1; 2; 4 3.0 1.9 4.1 5.6 2.4 3.9
SD 1 1.7 0.9 1.0 1.1 0.4 1.6
2 0.7 0.4 2.5 0.5 1.7 1.4
3 0.7 6.9 4.8 1.7 1.2 1.8
4 1.2 1.0 1.5 4.6 1.0 1.3
average 1–4 1.1 2.3 2.5 2.0 1.1 1.5
average 1; 2; 4 1.2 0.8 1.7 2.1 1.0 1.4
Abbreviations: x (left-right), y (anterior-posterior) and z (superior-inferior) direction; SD; standard deviation; average 1; 2; 4 (bold) excludes outlier case 3
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Large registration variability was observed for case 3,
most likely because of low image resolution (pixelspa-
cing 1.2 mm CT and 0.8 mm on MRI) and large slice
spacing of 3 mm on CT and 4.8 mm on MR. This was a
thoracic spine (T 7–8) case with MR acquired in non-
treatment position that made CT-MR registration
extremely challenging. Without consideration of this
outlier, average registration variability ranged from
0.8 mm to 1.7 mm for translation and 1.0° to 2.1° for
rotation.
Step 2: delineation of GTV and spinal cord
The variation of the GTV contours is shown in Table 4.
Variability was quantified by using the parameters SD
and range in x (Left-Right), y (Anterior-Posterior) and z
(Superior-Inferior) direction. On average the axial (X
and Y) and longitudinal (Z) standard variation was
1.5 mm, 1.6 mm, respectively. The range was on average
3.5 mm and 3.8 mm in axial and longitudinal direction.
For the spinal cord, the delineation variability (1 SD)
between the five institutions was 1 mm in axial direction
averaged over the four cases.
Step 3: delineation of CTV and organ at risk spinal cord
Based on the consensus GTV, all institutions created a
CTV which again resulted in variabilities of 0.8 mm and
1.2 mm in axial and longitudinal directions, respectively.
The range was on average 1.8 mm and 2.8 mm in axial
and longitudinal direction as shown in Table 5.
Step 4 delineation of PTV
CTV-to-PTV margins ranged between 0 mm and 2 mm
according to institutional protocol [17, 25]. Margins for
generation of the PRV spinal cord ranged between 1 mm
and 2 mm.
Step 5: treatment planning
All participating institutions generated one treatment plan
for each case using previously generated consensus struc-
tures. The dosimetric analyses are listed in Tables 6 and 7.
Dmin to the PTV was 7.5 ± 1.8 Gy averaged over all
cases and institutions. The D90 was 17.4 ± 1.0 Gy on
average and 86.9 % ± 5.2 of the PTV was covered by the
prescribed dose of 18 Gy.
Dmax to the PRV_SCconsensus (spinal cord + 1 mm) was
10.5 Gy on average and variability (1 SD) of Dmax was
1.6 Gy averaged over all cases and institutions. Dmax in
the PRV_SC was smaller than 12 Gy in 18 of 20 treat-
ment plan trials developed by the participating institu-
tions. For the two deviating trials, the D0,1ccm was 11 Gy
in maximum. The highest variability between institu-
tions was observed in case 4, where Dmax to the PRV_SC
ranged between 6.4 Gy and 11.7 Gy. The mean absolute
PRV_SC volume exposed to maximum 10 Gy was
0.1 cm3 with a maximum of 0.39 cm3.
In Fig. 3 the ICRU dose report parameters are shown
for one example case (case 1) for all 5 participating institu-
tions. Good agreement is demonstrated for the parameters
D90 and Dmean with a maximum deviation of 2.4 Gy and
1.1 Gy. A higher variability is demonstrated for the other
dose report parameters – especially for D98, D95 and Dmax
with a maximum difference of 4.9 Gy, 5.1 Gy and 4.6 Gy
for this example case. Over all cases, the maximum devi-
ation in D98 and D95 was 8.5 Gy and 7.6 Gy
Figure 4a illustrates the maximum dose to the plan-
ning risk volume spinal cord (Dmax PRV_SC) as a func-
tion of the minimum dose in the PTV (Dmin PTV).
Fig. 4b shows the dose to 0.1 cm3 of the spinal cord to
the D98 in the PTV. A very strong correlation can be
seen - especially between D0.1ccm(SC) and D98(PTV)
with a coefficient of determination of R2 = 0.81.
For all cases and all plans, the performance parameters
were calculated and analyzed. The detailed performance
Table 4 GTV definition variability between the five institutions
SD in mm Range in mm
Case X and Y Z X and Y Z
1 1.3 0.6 3.1 1.5
2 1.7 3.4 4.1 8.1
3 1.3 0.9 2.5 2.0
4 1.8 1.5 4.0 3.6
Average 1.5 1.6 3.5 3.8
Table 5 CTV definition variability between the five institutions
SD in mm Range in mm
Case X and Y Z X and Y Z
1 0.6 0.3 1.6 0.8
2 1.3 3.0 3.0 6.9
3 0.5 0.6 1.0 1.4
4 0.9 1.0 1.9 2.3
Average 0.8 1.2 1.8 2.8
Table 6 ICRU report parameters with average values over all
cases
PTV
Dmin in Gy 7.5 ±1.8
D98 in Gy 12.2 ±2.0
D95 in Gy 15.2 ±1.7
D90 in Gy 17.4 ±1.0
Dmean in Gy 19.4 ±0.8
D05 in Gy 21.6 ±1.3
D02 in Gy 21.9 ±1.4
Dmax in Gy 23.1 ±1.6
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parameters are listed in Table 8. Cov-RTOG was 87 %
on average and variability was 5 %; variability was largest
in case # 1 where PTV coverage ranged between 76 and
91 %. The CI-Paddick was 0.68 on average with small
variability of 0.08; the largest variability in CI-Paddick
was observed in case # 2 with a range of 0.76 and 0.91
between the institutions.
One additional plan was optimized based on the PTVin-
dividual of each case and institution. Doses to the consensus
PTV and consensus PRV_SC were evaluated in these
treatment plans to quantify the dosimetric consequences
of the image-registration and contouring uncertainties.
For the PTVindividual based planning process, the varia-
tions on planning performance was higher compared to
the consensus based planning. Performance parameters
are illustrated in Figs. 5 and 6. All discrete values are illus-
trated with blue dots. Mean values over all institutions are
shown in blue squares with standard deviation as error
bars. In Fig. 5, the minor deviation range according to the
respective protocol is shaded in light blue while major de-
viation rang is shown in shaded deeper blue.
Cov-RTOG decreased significantly if plans were
generated based on institution-individual contours (1c
- 4c). The mean values of consensus plans are cen-
tered in a range that would be considered as minor
deviations (<0.9) for all cases. This is contrasted with
the mean of the individual plans (1i –4i), which are
consistently in a range that would be considered a
major deviation (<0.8) (Fig. 5).
The CI-Paddick is less affected by the image registra-
tion and delineation variability. As shown in Fig. 6, the
consensus plans show on average a higher CI-Paddick
and smaller deviations.
For plans on individual PTVs, the average Dmin for
PTVconsensus drops from 7.5 ± 1.8 Gy to 6.5 ± 0.9 Gy. The
Dmax to PRV_SC increased from 10.5 ± 1.8 Gy to 12.2 ±
2.2 Gy. Similar results were observed for D0.1ccm which
increased from D0.1ccm 9.0 ± 1.5 Gy to 9.9 ± 1.8 Gy.
Discussion
The aim of this work is to quantify the variability of
treatment planning for spine radiosurgery in various
steps of the treatment planning process between five
international institutions. High variability was observed
during all steps of the planning process of image regis-
tration and contouring of tumor and target volumes. For
fair comparison, consensus registration parameters were
determined for image fusion and consensus contours
were developed for treatment plan optimization and
dosimetric evaluation. Additional individual treatment
plans were generated based on each individual institu-
tions spine RS practice and showed higher variabilities
in dose performance parameters for consensus target
volumes and organs at risk.
For the CT-MRI registration process, a high variability
was observed as reported by Ulin et al. [26]. None of the
MR images were acquired in treatment position. The in-
fluence of the 3D- voxel size seems to be the main factor
for registration performance. Case 1, 2 and 4 had an
average voxel size for CT and MR datasets of 1.0 mm
with an SD of 0.5 mm whereas case 3 had an voxel size
of 4.1 mm for CT and 2.9 mm for MR dataset. Deform-
ation of the vertebral column is well known but our re-
sults indicate that even in SBRT of a solitary vertebra,
reproducible patient positioning for MR imaging should
be performed to improve image registration. Addition-
ally, all institutions explained that automatic image
registration achieved unsatisfactory results and the
image registration was adjusted manually. Improved
software and methodologies specifically optimized for
the vertebral column may therefore be required. One
promising approach was suggested by Sohn et al. [27].
Table 7 Mean of doses and volumes to PRV_SC-Consensus
Dmax in
Gy
D0.1ccm in
Gy
V8Gy in
ccm
V10Gy in
ccm
Dose to PRV_SCconsensus
(Mean ± SD)
10.5 ±1.6 9.0 ±1.5 1.5 ±1.6 0.1 ±0.1
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Fig. 3 ICRU dose report parameters for one exemplary case (case 1) for all 5 participating institutions. The connecting lines should enhance the
distinction between institutions
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They present a segmental image fusion protocol which
allows an improved visualization of spinal tumors and
promises to achieve more consistent results. Neverthe-
less, image registration depends on datasets with high
spatial resolution and a reproducible positioning to avoid
or at least to minimize deformation.
For the delineation process, the highest variability was
observed for GTV delineation, which was about 1.5 mm
on average. The following step of CTV definition, which
was based on the consensus GTV contour, resulted in
lower variability between institutions of about 1 mm.
The CTV-to-PTV margin ranged between 0 mm and
2 mm. These variabilities clearly show the need for
further standardization of imaging and of delineation
guidelines. Recently, GTV delineation variability was
evaluated for SBRT of stage I non-small cell lung cancer
and the overall delineation variability was 2.1 mm [28].
Tseng et al. results support the importance of controlling
bulk patient motion and the practice of applying a plan-
ning organ-at-risk margin [29]. Several studies have in-
vestigated the inter-observer variability during the target
definition of other entities. All of them agreed that the
consistency of contouring can be improved by education
and training, consensus guidelines and multi-institutional
collaborations [30–33]. Also, a high degree of inter-
observer variability was seen for brain SRS [34, 35]. Devia-
tions between treatment planning based on individual and
consensus structures may show a potential influence on
patient outcome.
An overview of methods of spine radiosurgery for the
participating institutions was described by Guckenberger
et al. [17]. Good agreement was seen for the imaging
acquisitioning techniques and safety margins concepts.
However, treatment plan acceptance criteria varied sub-
stantially between all institutions. For this work, a D90 of
18 Gy in the PTV was suggested as parameter for plan ac-
ceptance. Even though the treatment planning was per-
formed based on consensus contours, the acceptance
criteria for D90 varied up to 3 Gy. This might be due to
different approaches to achieve target coverage and spar-
ing of the organs at risk, especially the spinal cord. The
tolerance dose to the spinal cord is limited to a maximum
dose while other institutions limit the dose to different
sub-volumes (0.1 cm3, 0.4 cm3 or 0.04 cm3). This dis-
agreement was already stated by Guckenberger et al. [17].
Additionally, changes/deviations in beam configuration
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Fig. 4 a/b Maximum planning risk volume spinal cord (PRV_SC) doses to PTV minimum doses and dose to 0,1ccm of spinal cord to PTV D98 for
all cases and institutions
Table 8 Mean performance parameters for all cases
Case CI-Paddick CI-RTOG HI-RTOG Cov-RTOG
1 0.67 ±0.08 1.11 ±0.17 1.98 ±0.34 0.86 ±0.06
2 0.63 ±0.08 1.19 ±0.24 1.64 ±0.17 0.86 ±0.05
3 0.70 ±0.07 1.09 ±0.15 1.90 ±0.31 0.87 ±0.04
4 0.72 ±0.05 1.10 ±0.12 1.90 ±0.44 0.89 ±0.05
mean 0.68 ±0.08 1.12 ±0.18 1.86 ±0.35 0.87 ±0.05
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1c 1i 2c 2i 3c 3i 4c 4i
C
o
v-
R
T
O
G
case and plan
Fig. 5 Performance parameters RTOG coverage for all analyzed
plans. Abbreviation: results of case 1–4 with consensus (c) and
individual (i) plans
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and optimization goals can lead to different planning re-
sults. Again, these variabilities show the need of strict and
consistent acceptance criteria. Similar findings were pub-
lished by Esposito et. al who investigated variability in
treatment planning for stereotactic radiotherapy of liver
metastasis [36]. In a multicenter study, they found signifi-
cant differences for target coverage and OAR sparing due
to different optimization strategies selected by the plan-
ners. Another multi-institutional study evaluated dosimet-
ric parameters for SBRT of lung lesions and how much
the guidelines provided in the literature are being
successfully implemented in a variety of clinics [37].
They analyzed PTV coverage and conformality of
their treatment plan and found that and the conform-
ality index of 50 % was the most difficult to meet de-
pending on tumor size and location.
Conclusion
Spinal radiosurgery (SRS) for vertebral metastases is a
rapidly evolving treatment modality that has shown
promising results in terms of pain and tumor control.
However, the methodology and implementation of SRS
has not yet been sufficiently standardized. Further stud-
ies are needed to establish whether the variability ob-
served in this study will influence the clinical outcomes.
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